Weight Loss Innovation R&D Forum

Agendas
14:00 - 15:30
  • 主持人 Moderator
  • 李小英, 复旦大学附属中山医院内分泌科教授
  • LI Xiaoying, Director of Department of Endocrinology, Zhongshan HospitalFudan University
14:00 - 14:30
  • 主题报告1
  • Keynote Speech 1
  • 以临床需求为导向的肥胖药物开发
  • Clinical Needs-Driven Drug Development for Obesity
  • 纪立农, 北京大学人民医院内分泌科主任
  • JI Linong, Director of Endocrinology and Metabolism Department, Peking University People's Hospital
14:30 - 15:00
  • 主题报告2
  • Keynote Speech 2
  • ActRII药物在增肌减脂领域的研发进展
  • Targeting ActRII for Muscle Preservation and Fat Reduction in Obesity
  • 王俊, 来凯医药有限公司副总裁，临床开发负责人
  • Gary WANG, VP, Head of Clinical Development, Laekna
15:00 - 15:30
  • 主题报告3
  • Keynote Speech 3
  • 超长效减重药物开发策略
  • Development of Ultra-Long-Acting Anti-Obesity Medications
  • 张媛媛, 北京质肽生物医药科技有限公司联合创始人，R&D高级副总裁
  • ZHANG Yuanyuan, Cofounder, R&D SVP of Beijing QL Biopharmaceutical Co., Ltd.
15:30 - 16:30
  • 主持人 Moderator
  • 崔一民, 中国医药创新促进会创新转化与临床开发专委会资深主任委员，北京大学临床药理研究所所长
  • CUI Yimin, Eminent Chairman of PhIRDA Innovation Translation and Clinical Development Specialty Committee Director of Institute of Clinical Pharmacology, Peking University
15:30 - 16:00
  • 主题报告4
  • Keynote Speech 4
  • 减重药物开发布局与趋势
  • Overview of Weight Loss Drug Development Landscape
  • 陈虹, 江苏恒瑞医药股份有限公司临床研发医学高级总监
  • CHEN Hong, Jiangsu Hengrui Pharmaceuticals Co., Ltd. Senior Director
16:00 - 16:30
  • 主题报告5
  • Keynote Speech 5
  • 减重药物创新研发的思考
  • Reflections on the Innovative Research and Development of Anti-Obesity Medicines
  • 程坚, 礼来公司高级医学总监
  • CHENG Jian, Senior Medical Director of Eli Lilly & Company
16:30 - 17:10
  • 主题讨论
  • Panel
  • 突围减重赛道：差异化竞争、支付瓶颈与临床价值回归
  • How to Navigate the Anti-Obesity Drug Development Space
    • 主持人 Moderator
  • 纪立农, 北京大学人民医院内分泌科主任
  • JI Linong, Director of Endocrinology and Metabolism Department, Peking University People's Hospital
    • Panel嘉宾 Panelist
  • 崔一民, 中国医药创新促进会创新转化与临床开发专委会资深主任委员，北京大学临床药理研究所所长
  • CUI Yimin, Eminent Chairman of PhIRDA Innovation Translation and Clinical Development Specialty Committee Director of Institute of Clinical Pharmacology, Peking University
  • 李小英, 复旦大学附属中山医院内分泌科教授
  • LI Xiaoying, Director of Department of Endocrinology, Zhongshan HospitalFudan University
  • 赵青威, 浙江大学医学院附属第一医院临床药学部主任
  • ZHAO Qingwei, Director of the Clinical Pharmacy Department, The First Affiliated Hospital, Zhejiang University School of Medicine
  • 林亮, 礼来亚洲基金合伙人
  • LIN Liang, Partner, LAV
  • 王庆华, 银诺医药董事长兼首席执行官
  • WANG Qinghua, INNOGEN Chairman and CEO
  • 钱镭, 信达制药集团首席研发官（综合产品线）
  • QIAN Lei, Chief R&D Officer，Innoventbio